Elizabeth Lamos is an Endocrinology/Metabolic physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 56 publications with 917 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20231 payment
- Horizon Therapeutics plcProgram year20231 payment
- Novo Nordisk IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
72.3%GLP-1 receptor agonist36.7%Trulicity39%Mounjaro36%Ozempic26%Part D<11 patientsBiguanide (metformin)17.6%Metformin Hcl57%Metformin Hcl Er43%Part D≥13 patients+ 4 more classes in this area
Hormonal (systemic)
23.2%l-Thyroxine23.2%Levothyroxine Sodium69%Synthroid32%Part D<11 patientsCardiovascular
4.5%Statin4.5%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Assessment of Online Transgender Healthcare Teaching Modules for Internal Medicine Residents and Fellows
Open Journal of Internal Medicine
2024 - 12545 Transgender Healthcare Online Curriculum: A Partnership Between An Academic Medical Center And Corrections Facility
Journal of the Endocrine Society
2024 - The effects of calcitonin on quality of life in hypothyroid patients – A pilot study
Endocrine and Metabolic Science
2023 - Challenges of Gender-Affirming Care in Incarcerated Transgender People
Endocrinology and Metabolism Clinics of North America
2023 - ODP410 Exposure to Transgender Teaching in Internal Medicine Residents and Established Providers
Journal of the Endocrine Society
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Gloria Reeves, MD
University of Maryland, Baltimore
Karen Kotloff, MD
University of Maryland, Baltimore
Christopher Plowe, MD
University of Maryland, Baltimore
Michael Domanski, MD
University of Maryland, Baltimore
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”